AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2012
Sep 14, 2012
30786_dirs_2012-09-14_13c92d4c-bc65-42c8-8edb-06f7b180bb9c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2012-09-12
Reporting Person: WADLER SANFORD (VP, General Counsel, Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-09-12 | Restricted Stock Units | $0 | A | 1000 | Acquired | Bio-Rad A Common Stock (1000) | Direct | |
| 2012-09-12 | Non-Qualified Stock Option (right to buy) | $107.32 | A | 3000 | Acquired | 2022-09-12 | Bio-Rad A Common Stock (3000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 12117 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A Common Stock.
F2: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
F3: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Registration Form
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13